Dear Organizers, For BraTS 2026 Task 2 (Pediatric Tumors), could you please confirm: 1) Does the final ranking use global DSC and global NSD only, or is global HD95 also included? Are lesion-wise/instance metrics used for ranking or only reported diagnostically? 2) How are "both-empty" regions (empty ground truth AND empty prediction) handled in the ranking (NaN-excluded vs counted)? 3) Are all six regions (ET, NETC, CC, ED, TC, WT) weighted equally in the final rank aggregation? 4) Are publicly released prior BraTS-PED pretrained weights / containers allowed in Task 2 final submissions? Thank you.

Created by Dauren Omarbekov daurenom
Hi @daurenom, Yes, you are allowed to use publicaly available models from prior BraTS-PED challenges. Best regards, Zhifan
@daurenom Yes, DSC and NSD metrics of all six regions will contribute to the final ranking, which will be computed as described [here](https://link.springer.com/chapter/10.1007/978-3-032-16365-3_1). Best regards, /Mehdi
To clarify point 3: do all 12 region-metric combinations (6 regions * DSC/NSD) contribute equally to the final ranking, and is aggregation performed over per-case ranks or over cohort-level metric means?
Hi @daurenom, Thanks for reaching out. 1- Global DSC and NSD will be considered for the final ranking. 2- Please note that NAN will not affect the ranking. 3- Yes, as detailed in the challenge [description](https://www.synapse.org/Synapse:syn74274097/wiki/639578) and [configuration file](https://github.com/BraTS/BraTS_evaluation/tree/main/brats_evaluation/configs) all six regions will be assessed. 4- I will ask my colleague to reply to this question. Best regards, /Mehdi

Task 2 - clarification on final ranking metrics page is loading…